Copyright
©The Author(s) 2022.
World J Gastroenterol. Mar 14, 2022; 28(10): 985-1008
Published online Mar 14, 2022. doi: 10.3748/wjg.v28.i10.985
Published online Mar 14, 2022. doi: 10.3748/wjg.v28.i10.985
Primary Malignancy | Characteristics | ||||||||||||||
Ref. | Year | Cases | Renal | Lung | Breast | Stomach | Colon | Sarcoma | Melanoma | Ovary | Thyroid | Other | Solitary mass | Multiple nodules | Diffuse involvement |
Ferrozzi et al[14] | 1997 | 20 | 2 | 6 | 3 | 3 | 1 | 2 | 2 | 1 | 11 | 2 | 7 | ||
Klein et al [15] | 1998 | 66 | 20 | 15 | 8 | 4 | 5 | 4 | 2 | 1 | 7 | 52 | 11 | 3 | |
Tsitouridis et al [16] | 2009 | 11 | 1 | 7 | 3 | 7 | 3 | 1 | |||||||
Angelleli et al [17] | 2012 | 17 | 8 | 4 | 3 | 2 | 7 | 9 | 1 | ||||||
Shi et al [18] | 2015 | 18 | 3 | 7 | 5 (stomach+colon) | 2 | 1 | 12 | 6 | ||||||
Choi et al [19] | 2015 | 36 | 17 | 2 | 5 | 7 | 1 | 1 | 1 | 2 | 29 | 7 | |||
Galia et al [20] | 2018 | 24 | 6 | 8 | 2 | 1 | 4 | 3 | 9 | 13 | 2 | ||||
Total | 192 | 57 | 49 | 19 | 12 | 8 | 11 | 7 | 5 | 6 | 13 | 127 | 51 | 14 | |
% of total | 30% | 26% | 10% | 7% | 5% | 6% | 4% | 3% | 3% | 7% | 66% | 27% | 7% |
Modality/procedure | Total cases | Renal | Lung | Breast | Stomach | Colon | Sarcoma | Melanoma | Ovary | Thyroid | Esophagus | Lymphoma | Other |
CT | 192 | 30% | 26% | 10% | 7% | 5% | 6% | 4% | 3% | 3% | 0% | 0% | 7% |
ERCP | 307 | 1% | 3% | 4% | 27% | 38% | 0% | 2% | 2% | 0% | 2% | 1% | 20% |
EUS-FNA | 515 | 40% | 20% | 6% | 2% | 9% | 3% | 10% | 3% | 1% | 2% | 0% | 3% |
Surgery | 399 | 63% | 3% | 3% | 3% | 6% | 7% | 4% | 5% | 0% | 0% | 0% | 6% |
Autopsy | 184 | 3% | 28% | 4% | 22% | 1% | 2% | 1% | 2% | 1% | 0% | 5% | 31% |
Weighted average1 | 1597 | 33% | 14% | 5% | 10% | 12% | 4% | 5% | 3% | 1% | 1% | 1% | 11% |
Unique characteristics/diagnostic clues | Major causes of malignant biliary obstruction | |
Renal cell carcinoma | Enhancing lesion on imaging. Most pancreatic metastases resectable and associated with a good prognosis. Can arise up to 32 years after diagnosis of primary tumor | Pancreatic metastasis (biliary obstruction rare) |
Lung cancer | Most reported in small cell lung cancer. Possible primary small cell biliary cancer | Pancreatic metastasis |
Gastric cancer | Most cases present after surgery for Borrmann 3 antral lesions. Possible need for double stenting due to gastric outlet obstruction | Lymph nodes, liver metastasis, direct invasion |
Colorectal cancer | Intraductal growth can mimic bile duct cancer | Liver metastasis, lymph nodes |
Breast cancer | Most reported in invasive lobular carcinoma. Possible duodenal obstructionCan arise up to 32 years after diagnosis of primary tumor | Lymph nodes, pancreatic metastasis |
Melanoma | Possible pancreato-biliary primary | Pancreatic metastasis |
Lymphoma | More common in non-Hodgkin's lymphoma. Possible pancreato-biliary primary | Lymph nodes |
Sarcoma | Possible pancreato-biliary primary | Pancreatic metastasis |
- Citation: Okamoto T. Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer. World J Gastroenterol 2022; 28(10): 985-1008
- URL: https://www.wjgnet.com/1007-9327/full/v28/i10/985.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i10.985